Yes – switching between neuromodulators is very common. Our providers at Novell primary care, weight loss, and aesthetics- Tallahassee discuss the options to best help you achieve the look you want.
At Novell Primary Care, Weight Loss and Aesthetics, we offer Jeuveau as another option for Botulinum Type A Neuromodulator as well as Dysport and Daxxify.
Unlike Dysport, Jeuveau dosing units are considered clinically comparable to Botox units, and many injections use a 1:1 conversion when transitioning between the two products. Jeuveau was developed specifically for aesthetic use and received FDA approval in 2019 for the Glabellar lines, while Botox has been approved for multiple treatment areas.
Since Jeuveau and Botox treatments have the same goal of smoothing out fine lines and wrinkles, the providers at Novell Primary Care, weight loss, and aesthetics can help you decide which one is a better option for your unique aesthetic goals and preferences.
If you are concerned with moderate to severe wrinkles, Botox and Jeuveu can be a good fit. Both Jeuveau and Botox typically begin showing results within five days to a week, with maximal improvement at about two weeks. Both neuromodulators last about three to four months, depending on the patient’s metabolism, dosage, and area treated.